PTGX
98.99 USD
-3.31%
Today
-5.01%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Protagonist Therapeutics Inc Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
6.51B
Avg Daily Volume
805.17K
52 Week High
107.84 USD
52 Week Low
39.6 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Top News
AbbVieInc
-1.94%
AirProd
+0.32%
AresManagement
-4.10%
Coeur
+2.59%
CFIndustries
+1.73%
California.Resources
+0.79%
CytomX.Therapeutics
+4.05%
DocuSign-Inc
-3.73%
Duolingo
-0.37%
Fair_Isaac
-13.78%
General_Mills
-3.29%
Hecla.Mining
+0.73%
IntuitiveS
-0.97%
Knight-Swift
+0.90%
Lucid
-2.17%
Lennar
+0.51%
Macys
-1.36%
MicroStrategy
-0.76%
MicronTech
-0.08%
Nebius.Group
+6.52%
NewmontM
+2.35%
NetflixInc
+0.96%
Ormat
+1.26%
Protagonist
-5.01%
Starbucks
-0.20%
SLGreen
+0.95%
SoFiTech
-0.12%
ConstellationBrands
+4.05%
T1.Energy
+12.29%
TradeDesk-Class-A
-2.34%
Vertex
+0.10%
WesternAlliance
-0.84%
Block
-0.38%
BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
reuters.com
3w ago
AbbVieInc
-1.94%
AirProd
+0.32%
AresManagement
-4.10%
Coeur
+2.59%
CFIndustries
+1.73%
California.Resources
+0.79%
CytomX.Therapeutics
+4.05%
DocuSign-Inc
-3.73%
Duolingo
-0.37%
Fair_Isaac
-13.78%
General_Mills
-3.29%
Hecla.Mining
+0.73%
IntuitiveS
-0.97%
Knight-Swift
+0.90%
Lucid
-2.17%
Lennar
+0.51%
Macys
-1.36%
MicroStrategy
-0.76%
MicronTech
-0.08%
Nebius.Group
+6.52%
NewmontM
+2.35%
NetflixInc
+0.96%
Ormat
+1.26%
Protagonist
-5.01%
Starbucks
-0.20%
SLGreen
+0.95%
ConstellationBrands
+4.05%
T1.Energy
+12.29%
TradeDesk-Class-A
-2.34%
Vertex
+0.10%
WesternAlliance
-0.84%
Block
-0.38%
BUZZ-U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies
reuters.com
3w ago
Johnson & Johnson Gets FDA Approval for Icotyde in Plaque Psoriasis — Update
tradingview.com
3w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
